Production (Stage)
Eastwood Bio-Medical Canada Inc.
EBM.V
TSX
| 01/31/2025 | 10/31/2024 | 07/31/2024 | 04/30/2024 | 01/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 27.86% | 15.84% | 3.98% | 26.12% | 21.79% |
| Total Depreciation and Amortization | 60.41% | 1.51% | -3.47% | -1.51% | -1.50% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -28.57% | 66.09% | -1.45% | 0.00% | 11.59% |
| Change in Net Operating Assets | -144.07% | -30.35% | -22.83% | -20.99% | -28.92% |
| Cash from Operations | 422.22% | -405.26% | -509.52% | 288.89% | 88.61% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -20.26% | 126.03% | -- | -- |
| Total Debt Repaid | -- | 13.73% | 5,225.00% | -153.14% | 36.00% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 138.55% | -60.00% | 382.76% | -137.50% | 36.15% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 166.30% | -854.55% | 144.30% | -88.49% | 55.98% |